Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Lipocine Inc (LPCN)

Lipocine Inc (LPCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Lipocine: Q3 Earnings Snapshot AP - Wed Nov 8, 2023

Lipocine: Q3 Earnings Snapshot

LPCN : 4.55 (+2.48%)
Lipocine to Present at the Cantor Fitzgerald Global Healthcare Conference PR Newswire - Tue Sep 19, 2023

/PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company focused on treating Central Nervous System (CNS) disorders, today announced that Dr....

LPCN : 4.55 (+2.48%)
Lipocine: Q2 Earnings Snapshot AP - Thu Aug 10, 2023

Lipocine: Q2 Earnings Snapshot

LPCN : 4.55 (+2.48%)
Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2023 PR Newswire - Thu Aug 10, 2023

/PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company focused on treating Central Nervous System (CNS) disorders, today announced financial...

LPCN : 4.55 (+2.48%)
LPCN 1148 Phase 2 Study Meets Primary Endpoint in Patients with Cirrhosis PR Newswire - Thu Jul 27, 2023

/PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company focused on treating Central Nervous System (CNS) disorders by leveraging its...

LPCN : 4.55 (+2.48%)
Lipocine to Present at H.C. Wainwright Annual Neuropsychiatry Virtual Conference PR Newswire - Wed Jun 14, 2023

/PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company focused on treating Central Nervous System (CNS) disorders by leveraging its...

LPCN : 4.55 (+2.48%)
Lipocine to Present LPCN 1148 and LPCN 1144 at the EASL Congress 2023 PR Newswire - Wed Jun 7, 2023

/PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company focused on treating Central Nervous System (CNS) disorders by leveraging its...

LPCN : 4.55 (+2.48%)
Positive Topline Clinical Results Support Streamlined Development Pathway for LPCN 1154, Lipocine's Oral Candidate for Rapid Relief of Depression PR Newswire - Tue May 16, 2023

/PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), today announced positive topline results from a pilot clinical PK bridge study of LPCN 1154 (oral brexanolone)...

LPCN : 4.55 (+2.48%)
Lipocine: Q1 Earnings Snapshot AP - Thu May 11, 2023

Lipocine: Q1 Earnings Snapshot

LPCN : 4.55 (+2.48%)
Lipocine Announces Financial Results for the First Quarter Ended March 31, 2023 PR Newswire - Thu May 11, 2023

/PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company focused on treating Central Nervous System (CNS) disorders by leveraging its...

LPCN : 4.55 (+2.48%)

Barchart Exclusives

This Dividend King Is Now One of BofA's Investment Best Ideas Barchart - Thu Apr 25, 6:30PM CDT
Discover why S&P Global, a seasoned Dividend King, has not only secured a spot on Bank of America's prestigious US 1 List, but also why analysts are bullish about its investment potential in the current economic climate. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot